KMDA vs KRRO

Kamada Ltd. vs Korro Bio, Inc. — Valuation Comparison 2026

KMDA

Pharmaceutical Preparations
Kamada Ltd.
Quality
1.9
out of 10
Value Trap
Price
$7.81
Last close
Models
11/13
Active
VS

KRRO

Pharmaceutical Preparations
Korro Bio, Inc.
Quality
5.1
out of 10
Value Trap
28
LOW
Price
$13.41
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType KMDA Fair ValueKMDA Upside KRRO Fair ValueKRRO Upside
Bayesian DCF Intrinsic $2.08 -73.4% $3.85 -71.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $3.86 -53.3%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.20 -71.9% $9.46 -29.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for KMDA vs KRRO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KMDA vs KRRO — Which Stock Is More Undervalued?

KRRO scores higher with a 5.1/10 quality rating vs KMDA's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Kamada Ltd. (KMDA) and Korro Bio, Inc. (KRRO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KMDA currently trades at $7.81 with a QOC of 1.9/10, while KRRO trades at $13.41 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).